Clinical Trials Directory

Trials / Unknown

UnknownNCT04523974

Preemptive and Precise Intervention for CKD-SHPT

Preemptive Surgical Intervention and Precise Efficacy Evaluation for Hyperparathyroidism Secondary to Chronic Kidney Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Shanghai Zhongshan Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Through multi-center randomized controlled trial studies on preemptive surgical intervention in patients with chronic kidney disease (CKD) - secondary hyperparathyroidism (SHPT), to precisely evaluate the safety and effectiveness during perioperative period, and the long-term outcomes by 1-year follow-up. The follow-ups include the evaluation of the overall quality of life, calcium and phosphorus metabolism, hyperparathyroidism level, vitamin D metabolism, bone mineral density, soft tissue and vascular calcification.

Conditions

Interventions

TypeNameDescription
PROCEDUREPreemptive Surgical Intervention and Precise Efficacy Evaluation of CKD-SHPT1. Preemptive surgical intervention for CKD-SHPT patients with poor calcium and phosphorus metabolism controlled by drugs; 2. Rapid immunoreactive parathyroid hormone detection technology during peri-operative period.

Timeline

Start date
2020-10-01
Primary completion
2022-09-30
Completion
2022-12-31
First posted
2020-08-24
Last updated
2020-08-24

Source: ClinicalTrials.gov record NCT04523974. Inclusion in this directory is not an endorsement.

Preemptive and Precise Intervention for CKD-SHPT (NCT04523974) · Clinical Trials Directory